nodes	percent_of_prediction	percent_of_DWPC	metapath
Sulindac—SLC22A6—Doxycycline—malaria	0.102	0.188	CbGbCtD
Sulindac—CYP1A1—Quinine—malaria	0.0793	0.146	CbGbCtD
Sulindac—PTGS2—Dapsone—malaria	0.0712	0.131	CbGbCtD
Sulindac—CYP1A1—Quinidine—malaria	0.0697	0.128	CbGbCtD
Sulindac—PTGS1—Dapsone—malaria	0.0601	0.111	CbGbCtD
Sulindac—CYP1A2—Proguanil—malaria	0.055	0.101	CbGbCtD
Sulindac—CYP1A2—Pentoxifylline—malaria	0.0395	0.0727	CbGbCtD
Sulindac—CYP1A2—Quinine—malaria	0.0354	0.0652	CbGbCtD
Sulindac—CYP1A2—Quinidine—malaria	0.0311	0.0573	CbGbCtD
Sulindac—PTGDR2—hematopoietic system—malaria	0.0081	0.0719	CbGeAlD
Sulindac—AKR1B1—blood plasma—malaria	0.00779	0.0691	CbGeAlD
Sulindac—MAPK3—endothelium—malaria	0.00636	0.0564	CbGeAlD
Sulindac—MAPK3—blood plasma—malaria	0.00564	0.0501	CbGeAlD
Sulindac—PTGDR2—blood—malaria	0.00537	0.0476	CbGeAlD
Sulindac—AKR1B1—saliva-secreting gland—malaria	0.00451	0.04	CbGeAlD
Sulindac—AKR1B1—hematopoietic system—malaria	0.00431	0.0382	CbGeAlD
Sulindac—AKR1B1—kidney—malaria	0.00353	0.0313	CbGeAlD
Sulindac—PPARD—hematopoietic system—malaria	0.00339	0.03	CbGeAlD
Sulindac—PTGDR2—brain—malaria	0.00333	0.0296	CbGeAlD
Sulindac—MAPK3—saliva-secreting gland—malaria	0.00327	0.029	CbGeAlD
Sulindac—MAPK3—hematopoietic system—malaria	0.00312	0.0277	CbGeAlD
Sulindac—AKR1B1—digestive system—malaria	0.00299	0.0266	CbGeAlD
Sulindac—AKR1B1—blood—malaria	0.00285	0.0253	CbGeAlD
Sulindac—AKR1B1—bone marrow—malaria	0.00276	0.0245	CbGeAlD
Sulindac—MAPK3—kidney—malaria	0.00256	0.0227	CbGeAlD
Sulindac—PPARD—digestive system—malaria	0.00235	0.0209	CbGeAlD
Sulindac—AKR1B1—liver—malaria	0.00223	0.0198	CbGeAlD
Sulindac—MAPK3—digestive system—malaria	0.00217	0.0193	CbGeAlD
Sulindac—MAPK3—blood—malaria	0.00207	0.0183	CbGeAlD
Sulindac—MAPK3—bone marrow—malaria	0.002	0.0178	CbGeAlD
Sulindac—CYP1A2—blood plasma—malaria	0.00177	0.0157	CbGeAlD
Sulindac—AKR1B1—brain—malaria	0.00177	0.0157	CbGeAlD
Sulindac—PPARD—liver—malaria	0.00175	0.0156	CbGeAlD
Sulindac—PTGS1—endothelium—malaria	0.00173	0.0153	CbGeAlD
Sulindac—PTGS2—endothelium—malaria	0.00165	0.0146	CbGeAlD
Sulindac—MAPK3—liver—malaria	0.00162	0.0143	CbGeAlD
Sulindac—PTGS1—blood plasma—malaria	0.00153	0.0136	CbGeAlD
Sulindac—PTGS2—blood plasma—malaria	0.00147	0.013	CbGeAlD
Sulindac—PPARD—brain—malaria	0.00139	0.0124	CbGeAlD
Sulindac—MAPK3—brain—malaria	0.00128	0.0114	CbGeAlD
Sulindac—SLC22A6—brain—malaria	0.000982	0.00871	CbGeAlD
Sulindac—CYP1A2—hematopoietic system—malaria	0.000979	0.00868	CbGeAlD
Sulindac—CYP1A1—hematopoietic system—malaria	0.000966	0.00857	CbGeAlD
Sulindac—PTGS1—hematopoietic system—malaria	0.000848	0.00753	CbGeAlD
Sulindac—PTGS2—hematopoietic system—malaria	0.000811	0.00719	CbGeAlD
Sulindac—CYP1A1—kidney—malaria	0.000791	0.00702	CbGeAlD
Sulindac—ALB—liver—malaria	0.000771	0.00684	CbGeAlD
Sulindac—PTGS1—kidney—malaria	0.000695	0.00617	CbGeAlD
Sulindac—CYP1A2—digestive system—malaria	0.000681	0.00604	CbGeAlD
Sulindac—CYP1A1—digestive system—malaria	0.000671	0.00596	CbGeAlD
Sulindac—PTGS2—kidney—malaria	0.000665	0.0059	CbGeAlD
Sulindac—CYP1A2—blood—malaria	0.000649	0.00575	CbGeAlD
Sulindac—CYP1A1—blood—malaria	0.00064	0.00568	CbGeAlD
Sulindac—ALB—brain—malaria	0.000612	0.00543	CbGeAlD
Sulindac—PTGS1—digestive system—malaria	0.00059	0.00523	CbGeAlD
Sulindac—PTGS2—digestive system—malaria	0.000564	0.005	CbGeAlD
Sulindac—PTGS1—blood—malaria	0.000562	0.00499	CbGeAlD
Sulindac—Neutropenia—Quinidine barbiturate—malaria	0.000537	0.00233	CcSEcCtD
Sulindac—PTGS2—blood—malaria	0.000537	0.00477	CbGeAlD
Sulindac—Agranulocytosis—Quinine—malaria	0.00053	0.0023	CcSEcCtD
Sulindac—Agranulocytosis—Quinidine—malaria	0.00053	0.0023	CcSEcCtD
Sulindac—Convulsion—Sulfadiazine—malaria	0.000526	0.00228	CcSEcCtD
Sulindac—Photosensitivity reaction—Quinidine barbiturate—malaria	0.000525	0.00228	CcSEcCtD
Sulindac—PTGS2—bone marrow—malaria	0.00052	0.00461	CbGeAlD
Sulindac—Arthralgia—Sulfadiazine—malaria	0.000517	0.00224	CcSEcCtD
Sulindac—Diarrhoea—Proguanil—malaria	0.000511	0.00222	CcSEcCtD
Sulindac—Hepatitis—Quinidine—malaria	0.00051	0.00221	CcSEcCtD
Sulindac—Hepatitis—Quinine—malaria	0.00051	0.00221	CcSEcCtD
Sulindac—Stevens-Johnson syndrome—Quinidine barbiturate—malaria	0.000508	0.0022	CcSEcCtD
Sulindac—CYP1A2—liver—malaria	0.000507	0.0045	CbGeAlD
Sulindac—Renal failure—Quinidine barbiturate—malaria	0.000504	0.00219	CcSEcCtD
Sulindac—Tinnitus—Dapsone—malaria	0.000501	0.00217	CcSEcCtD
Sulindac—CYP1A1—liver—malaria	0.0005	0.00444	CbGeAlD
Sulindac—Jaundice—Quinidine barbiturate—malaria	0.000499	0.00217	CcSEcCtD
Sulindac—Jaundice—Pentoxifylline—malaria	0.000499	0.00216	CcSEcCtD
Sulindac—Conjunctivitis—Pentoxifylline—malaria	0.000497	0.00216	CcSEcCtD
Sulindac—Anaphylactic shock—Sulfadiazine—malaria	0.000496	0.00215	CcSEcCtD
Sulindac—Erythema multiforme—Clindamycin—malaria	0.000491	0.00213	CcSEcCtD
Sulindac—Sweating—Quinidine barbiturate—malaria	0.000491	0.00213	CcSEcCtD
Sulindac—Visual impairment—Quinine—malaria	0.000491	0.00213	CcSEcCtD
Sulindac—Visual impairment—Quinidine—malaria	0.000491	0.00213	CcSEcCtD
Sulindac—Sweating—Pentoxifylline—malaria	0.00049	0.00213	CcSEcCtD
Sulindac—Thrombocytopenia—Sulfadiazine—malaria	0.000485	0.00211	CcSEcCtD
Sulindac—Epistaxis—Pentoxifylline—malaria	0.000482	0.00209	CcSEcCtD
Sulindac—Flushing—Clindamycin—malaria	0.000482	0.00209	CcSEcCtD
Sulindac—Erythema multiforme—Quinine—malaria	0.000482	0.00209	CcSEcCtD
Sulindac—Erythema multiforme—Quinidine—malaria	0.000482	0.00209	CcSEcCtD
Sulindac—Agranulocytosis—Quinidine barbiturate—malaria	0.000478	0.00208	CcSEcCtD
Sulindac—Tinnitus—Quinine—malaria	0.000475	0.00206	CcSEcCtD
Sulindac—Tinnitus—Quinidine—malaria	0.000475	0.00206	CcSEcCtD
Sulindac—Vomiting—Proguanil—malaria	0.000475	0.00206	CcSEcCtD
Sulindac—Flushing—Quinidine—malaria	0.000473	0.00205	CcSEcCtD
Sulindac—Flushing—Quinine—malaria	0.000473	0.00205	CcSEcCtD
Sulindac—Anorexia—Sulfadiazine—malaria	0.000472	0.00205	CcSEcCtD
Sulindac—Rash—Proguanil—malaria	0.000471	0.00204	CcSEcCtD
Sulindac—Dermatitis—Proguanil—malaria	0.00047	0.00204	CcSEcCtD
Sulindac—Headache—Proguanil—malaria	0.000468	0.00203	CcSEcCtD
Sulindac—Hepatitis—Quinidine barbiturate—malaria	0.00046	0.002	CcSEcCtD
Sulindac—Hepatitis—Pentoxifylline—malaria	0.000459	0.00199	CcSEcCtD
Sulindac—Chills—Quinidine—malaria	0.000457	0.00199	CcSEcCtD
Sulindac—Chills—Quinine—malaria	0.000457	0.00199	CcSEcCtD
Sulindac—Musculoskeletal discomfort—Sulfadiazine—malaria	0.000452	0.00196	CcSEcCtD
Sulindac—Insomnia—Sulfadiazine—malaria	0.000448	0.00195	CcSEcCtD
Sulindac—Flatulence—Clindamycin—malaria	0.000446	0.00193	CcSEcCtD
Sulindac—Nausea—Proguanil—malaria	0.000444	0.00193	CcSEcCtD
Sulindac—Visual impairment—Quinidine barbiturate—malaria	0.000443	0.00192	CcSEcCtD
Sulindac—Dysgeusia—Clindamycin—malaria	0.000443	0.00192	CcSEcCtD
Sulindac—Vision blurred—Dapsone—malaria	0.000441	0.00191	CcSEcCtD
Sulindac—Erythema multiforme—Quinidine barbiturate—malaria	0.000435	0.00189	CcSEcCtD
Sulindac—Decreased appetite—Sulfadiazine—malaria	0.000431	0.00187	CcSEcCtD
Sulindac—Tinnitus—Quinidine barbiturate—malaria	0.000429	0.00186	CcSEcCtD
Sulindac—Flushing—Quinidine barbiturate—malaria	0.000427	0.00185	CcSEcCtD
Sulindac—Flushing—Pentoxifylline—malaria	0.000426	0.00185	CcSEcCtD
Sulindac—PTGS2—liver—malaria	0.00042	0.00373	CbGeAlD
Sulindac—Vertigo—Dapsone—malaria	0.00042	0.00182	CcSEcCtD
Sulindac—Vision blurred—Quinine—malaria	0.000418	0.00181	CcSEcCtD
Sulindac—Vision blurred—Quinidine—malaria	0.000418	0.00181	CcSEcCtD
Sulindac—Anaemia—Clindamycin—malaria	0.000418	0.00181	CcSEcCtD
Sulindac—Chills—Quinidine barbiturate—malaria	0.000413	0.00179	CcSEcCtD
Sulindac—Arrhythmia—Pentoxifylline—malaria	0.00041	0.00178	CcSEcCtD
Sulindac—Vertigo—Clindamycin—malaria	0.000406	0.00176	CcSEcCtD
Sulindac—Angioedema—Quinidine—malaria	0.000405	0.00176	CcSEcCtD
Sulindac—Angioedema—Quinine—malaria	0.000405	0.00176	CcSEcCtD
Sulindac—Gastrointestinal pain—Sulfadiazine—malaria	0.000405	0.00176	CcSEcCtD
Sulindac—Leukopenia—Clindamycin—malaria	0.000405	0.00176	CcSEcCtD
Sulindac—Vertigo—Quinidine—malaria	0.000399	0.00173	CcSEcCtD
Sulindac—Vertigo—Quinine—malaria	0.000399	0.00173	CcSEcCtD
Sulindac—Syncope—Quinidine—malaria	0.000398	0.00173	CcSEcCtD
Sulindac—Syncope—Quinine—malaria	0.000398	0.00173	CcSEcCtD
Sulindac—Leukopenia—Quinine—malaria	0.000397	0.00172	CcSEcCtD
Sulindac—Leukopenia—Quinidine—malaria	0.000397	0.00172	CcSEcCtD
Sulindac—CYP1A1—brain—malaria	0.000397	0.00352	CbGeAlD
Sulindac—Flatulence—Pentoxifylline—malaria	0.000394	0.00171	CcSEcCtD
Sulindac—Urticaria—Sulfadiazine—malaria	0.000394	0.00171	CcSEcCtD
Sulindac—Tension—Quinidine barbiturate—malaria	0.000393	0.00171	CcSEcCtD
Sulindac—Tension—Pentoxifylline—malaria	0.000392	0.0017	CcSEcCtD
Sulindac—Palpitations—Quinidine—malaria	0.000392	0.0017	CcSEcCtD
Sulindac—Palpitations—Quinine—malaria	0.000392	0.0017	CcSEcCtD
Sulindac—Body temperature increased—Sulfadiazine—malaria	0.000392	0.0017	CcSEcCtD
Sulindac—Dysgeusia—Pentoxifylline—malaria	0.000391	0.0017	CcSEcCtD
Sulindac—Hypertension—Clindamycin—malaria	0.00039	0.00169	CcSEcCtD
Sulindac—Loss of consciousness—Quinidine—malaria	0.00039	0.00169	CcSEcCtD
Sulindac—Loss of consciousness—Quinine—malaria	0.00039	0.00169	CcSEcCtD
Sulindac—Nervousness—Quinidine barbiturate—malaria	0.000389	0.00169	CcSEcCtD
Sulindac—Nervousness—Pentoxifylline—malaria	0.000388	0.00169	CcSEcCtD
Sulindac—Convulsion—Quinine—malaria	0.000384	0.00167	CcSEcCtD
Sulindac—Convulsion—Quinidine—malaria	0.000384	0.00167	CcSEcCtD
Sulindac—Discomfort—Clindamycin—malaria	0.00038	0.00165	CcSEcCtD
Sulindac—Myalgia—Quinidine—malaria	0.000378	0.00164	CcSEcCtD
Sulindac—Chest pain—Quinidine—malaria	0.000378	0.00164	CcSEcCtD
Sulindac—Chest pain—Quinine—malaria	0.000378	0.00164	CcSEcCtD
Sulindac—Myalgia—Quinine—malaria	0.000378	0.00164	CcSEcCtD
Sulindac—Vision blurred—Quinidine barbiturate—malaria	0.000377	0.00164	CcSEcCtD
Sulindac—Vision blurred—Pentoxifylline—malaria	0.000377	0.00164	CcSEcCtD
Sulindac—Tachycardia—Dapsone—malaria	0.000372	0.00162	CcSEcCtD
Sulindac—Ill-defined disorder—Pentoxifylline—malaria	0.000371	0.00161	CcSEcCtD
Sulindac—Anaemia—Pentoxifylline—malaria	0.000369	0.0016	CcSEcCtD
Sulindac—Anaphylactic shock—Clindamycin—malaria	0.000369	0.0016	CcSEcCtD
Sulindac—Angioedema—Quinidine barbiturate—malaria	0.000366	0.00159	CcSEcCtD
Sulindac—Angioedema—Pentoxifylline—malaria	0.000365	0.00159	CcSEcCtD
Sulindac—Hypersensitivity—Sulfadiazine—malaria	0.000365	0.00159	CcSEcCtD
Sulindac—Oedema—Quinidine—malaria	0.000362	0.00157	CcSEcCtD
Sulindac—Oedema—Quinine—malaria	0.000362	0.00157	CcSEcCtD
Sulindac—Thrombocytopenia—Clindamycin—malaria	0.000361	0.00157	CcSEcCtD
Sulindac—Malaise—Pentoxifylline—malaria	0.00036	0.00156	CcSEcCtD
Sulindac—Vertigo—Quinidine barbiturate—malaria	0.00036	0.00156	CcSEcCtD
Sulindac—Syncope—Quinidine barbiturate—malaria	0.000359	0.00156	CcSEcCtD
Sulindac—Leukopenia—Quinidine barbiturate—malaria	0.000358	0.00156	CcSEcCtD
Sulindac—Leukopenia—Pentoxifylline—malaria	0.000358	0.00155	CcSEcCtD
Sulindac—Shock—Quinidine—malaria	0.000356	0.00155	CcSEcCtD
Sulindac—Shock—Quinine—malaria	0.000356	0.00155	CcSEcCtD
Sulindac—Thrombocytopenia—Quinine—malaria	0.000355	0.00154	CcSEcCtD
Sulindac—Thrombocytopenia—Quinidine—malaria	0.000355	0.00154	CcSEcCtD
Sulindac—Palpitations—Quinidine barbiturate—malaria	0.000354	0.00154	CcSEcCtD
Sulindac—Tachycardia—Quinidine—malaria	0.000353	0.00153	CcSEcCtD
Sulindac—Tachycardia—Quinine—malaria	0.000353	0.00153	CcSEcCtD
Sulindac—Palpitations—Pentoxifylline—malaria	0.000353	0.00153	CcSEcCtD
Sulindac—Loss of consciousness—Quinidine barbiturate—malaria	0.000352	0.00153	CcSEcCtD
Sulindac—Pruritus—Sulfadiazine—malaria	0.000351	0.00152	CcSEcCtD
Sulindac—Hyperhidrosis—Quinidine—malaria	0.00035	0.00152	CcSEcCtD
Sulindac—Hyperhidrosis—Quinine—malaria	0.00035	0.00152	CcSEcCtD
Sulindac—PTGS1—brain—malaria	0.000349	0.00309	CbGeAlD
Sulindac—Convulsion—Quinidine barbiturate—malaria	0.000347	0.00151	CcSEcCtD
Sulindac—Convulsion—Pentoxifylline—malaria	0.000346	0.0015	CcSEcCtD
Sulindac—Anorexia—Quinine—malaria	0.000345	0.0015	CcSEcCtD
Sulindac—Anorexia—Quinidine—malaria	0.000345	0.0015	CcSEcCtD
Sulindac—Insomnia—Dapsone—malaria	0.000345	0.0015	CcSEcCtD
Sulindac—Hypertension—Pentoxifylline—malaria	0.000345	0.0015	CcSEcCtD
Sulindac—Hypotension—Clindamycin—malaria	0.000345	0.0015	CcSEcCtD
Sulindac—Chest pain—Quinidine barbiturate—malaria	0.000341	0.00148	CcSEcCtD
Sulindac—Myalgia—Quinidine barbiturate—malaria	0.000341	0.00148	CcSEcCtD
Sulindac—Arthralgia—Quinidine barbiturate—malaria	0.000341	0.00148	CcSEcCtD
Sulindac—Myalgia—Pentoxifylline—malaria	0.00034	0.00148	CcSEcCtD
Sulindac—Chest pain—Pentoxifylline—malaria	0.00034	0.00148	CcSEcCtD
Sulindac—Diarrhoea—Sulfadiazine—malaria	0.000339	0.00147	CcSEcCtD
Sulindac—Hypotension—Quinidine—malaria	0.000338	0.00147	CcSEcCtD
Sulindac—Hypotension—Quinine—malaria	0.000338	0.00147	CcSEcCtD
Sulindac—Discomfort—Pentoxifylline—malaria	0.000336	0.00146	CcSEcCtD
Sulindac—PTGS2—brain—malaria	0.000333	0.00296	CbGeAlD
Sulindac—Musculoskeletal discomfort—Quinidine—malaria	0.00033	0.00143	CcSEcCtD
Sulindac—Musculoskeletal discomfort—Quinine—malaria	0.00033	0.00143	CcSEcCtD
Sulindac—Dyspnoea—Clindamycin—malaria	0.000329	0.00143	CcSEcCtD
Sulindac—Oedema—Quinidine barbiturate—malaria	0.000327	0.00142	CcSEcCtD
Sulindac—Anaphylactic shock—Pentoxifylline—malaria	0.000326	0.00142	CcSEcCtD
Sulindac—Oedema—Pentoxifylline—malaria	0.000326	0.00142	CcSEcCtD
Sulindac—Dyspepsia—Clindamycin—malaria	0.000325	0.00141	CcSEcCtD
Sulindac—Dyspnoea—Quinidine—malaria	0.000323	0.0014	CcSEcCtD
Sulindac—Dyspnoea—Quinine—malaria	0.000323	0.0014	CcSEcCtD
Sulindac—Shock—Quinidine barbiturate—malaria	0.000321	0.0014	CcSEcCtD
Sulindac—Shock—Pentoxifylline—malaria	0.000321	0.00139	CcSEcCtD
Sulindac—Thrombocytopenia—Quinidine barbiturate—malaria	0.00032	0.00139	CcSEcCtD
Sulindac—Thrombocytopenia—Pentoxifylline—malaria	0.000319	0.00139	CcSEcCtD
Sulindac—Tachycardia—Quinidine barbiturate—malaria	0.000319	0.00138	CcSEcCtD
Sulindac—Tachycardia—Pentoxifylline—malaria	0.000318	0.00138	CcSEcCtD
Sulindac—Fatigue—Clindamycin—malaria	0.000318	0.00138	CcSEcCtD
Sulindac—Hyperhidrosis—Quinidine barbiturate—malaria	0.000316	0.00137	CcSEcCtD
Sulindac—Constipation—Clindamycin—malaria	0.000316	0.00137	CcSEcCtD
Sulindac—Hyperhidrosis—Pentoxifylline—malaria	0.000315	0.00137	CcSEcCtD
Sulindac—Vomiting—Sulfadiazine—malaria	0.000315	0.00137	CcSEcCtD
Sulindac—Decreased appetite—Quinidine—malaria	0.000315	0.00137	CcSEcCtD
Sulindac—Decreased appetite—Quinine—malaria	0.000315	0.00137	CcSEcCtD
Sulindac—Rash—Sulfadiazine—malaria	0.000313	0.00136	CcSEcCtD
Sulindac—Dermatitis—Sulfadiazine—malaria	0.000312	0.00136	CcSEcCtD
Sulindac—Gastrointestinal pain—Dapsone—malaria	0.000312	0.00135	CcSEcCtD
Sulindac—Anorexia—Quinidine barbiturate—malaria	0.000311	0.00135	CcSEcCtD
Sulindac—Anorexia—Pentoxifylline—malaria	0.000311	0.00135	CcSEcCtD
Sulindac—Headache—Sulfadiazine—malaria	0.00031	0.00135	CcSEcCtD
Sulindac—Hypotension—Quinidine barbiturate—malaria	0.000305	0.00133	CcSEcCtD
Sulindac—Hypotension—Pentoxifylline—malaria	0.000305	0.00132	CcSEcCtD
Sulindac—Gastrointestinal pain—Clindamycin—malaria	0.000302	0.00131	CcSEcCtD
Sulindac—Body temperature increased—Dapsone—malaria	0.000302	0.00131	CcSEcCtD
Sulindac—Feeling abnormal—Quinine—malaria	0.000298	0.0013	CcSEcCtD
Sulindac—Feeling abnormal—Quinidine—malaria	0.000298	0.0013	CcSEcCtD
Sulindac—Musculoskeletal discomfort—Quinidine barbiturate—malaria	0.000298	0.00129	CcSEcCtD
Sulindac—Musculoskeletal discomfort—Pentoxifylline—malaria	0.000297	0.00129	CcSEcCtD
Sulindac—Gastrointestinal pain—Quinine—malaria	0.000296	0.00129	CcSEcCtD
Sulindac—Gastrointestinal pain—Quinidine—malaria	0.000296	0.00129	CcSEcCtD
Sulindac—Insomnia—Pentoxifylline—malaria	0.000295	0.00128	CcSEcCtD
Sulindac—Nausea—Sulfadiazine—malaria	0.000294	0.00128	CcSEcCtD
Sulindac—Urticaria—Clindamycin—malaria	0.000293	0.00127	CcSEcCtD
Sulindac—Body temperature increased—Clindamycin—malaria	0.000292	0.00127	CcSEcCtD
Sulindac—Dyspnoea—Quinidine barbiturate—malaria	0.000291	0.00126	CcSEcCtD
Sulindac—Dyspnoea—Pentoxifylline—malaria	0.000291	0.00126	CcSEcCtD
Sulindac—Somnolence—Quinidine barbiturate—malaria	0.000291	0.00126	CcSEcCtD
Sulindac—Somnolence—Pentoxifylline—malaria	0.00029	0.00126	CcSEcCtD
Sulindac—Urticaria—Quinine—malaria	0.000288	0.00125	CcSEcCtD
Sulindac—Urticaria—Quinidine—malaria	0.000288	0.00125	CcSEcCtD
Sulindac—Dyspepsia—Pentoxifylline—malaria	0.000287	0.00125	CcSEcCtD
Sulindac—Body temperature increased—Quinidine—malaria	0.000286	0.00124	CcSEcCtD
Sulindac—Body temperature increased—Quinine—malaria	0.000286	0.00124	CcSEcCtD
Sulindac—Decreased appetite—Quinidine barbiturate—malaria	0.000284	0.00123	CcSEcCtD
Sulindac—Decreased appetite—Pentoxifylline—malaria	0.000284	0.00123	CcSEcCtD
Sulindac—Constipation—Quinidine barbiturate—malaria	0.000279	0.00121	CcSEcCtD
Sulindac—Constipation—Pentoxifylline—malaria	0.000279	0.00121	CcSEcCtD
Sulindac—Hypersensitivity—Clindamycin—malaria	0.000272	0.00118	CcSEcCtD
Sulindac—Feeling abnormal—Quinidine barbiturate—malaria	0.000269	0.00117	CcSEcCtD
Sulindac—Feeling abnormal—Pentoxifylline—malaria	0.000269	0.00117	CcSEcCtD
Sulindac—Gastrointestinal pain—Quinidine barbiturate—malaria	0.000267	0.00116	CcSEcCtD
Sulindac—Hypersensitivity—Quinidine—malaria	0.000267	0.00116	CcSEcCtD
Sulindac—Hypersensitivity—Quinine—malaria	0.000267	0.00116	CcSEcCtD
Sulindac—Gastrointestinal pain—Pentoxifylline—malaria	0.000267	0.00116	CcSEcCtD
Sulindac—Asthenia—Clindamycin—malaria	0.000265	0.00115	CcSEcCtD
Sulindac—Pruritus—Clindamycin—malaria	0.000261	0.00113	CcSEcCtD
Sulindac—Asthenia—Quinine—malaria	0.00026	0.00113	CcSEcCtD
Sulindac—Asthenia—Quinidine—malaria	0.00026	0.00113	CcSEcCtD
Sulindac—Urticaria—Quinidine barbiturate—malaria	0.00026	0.00113	CcSEcCtD
Sulindac—Urticaria—Pentoxifylline—malaria	0.000259	0.00112	CcSEcCtD
Sulindac—Body temperature increased—Quinidine barbiturate—malaria	0.000258	0.00112	CcSEcCtD
Sulindac—Body temperature increased—Pentoxifylline—malaria	0.000258	0.00112	CcSEcCtD
Sulindac—Pruritus—Quinidine—malaria	0.000256	0.00111	CcSEcCtD
Sulindac—Pruritus—Quinine—malaria	0.000256	0.00111	CcSEcCtD
Sulindac—Diarrhoea—Clindamycin—malaria	0.000253	0.0011	CcSEcCtD
Sulindac—Diarrhoea—Quinine—malaria	0.000248	0.00108	CcSEcCtD
Sulindac—Diarrhoea—Quinidine—malaria	0.000248	0.00108	CcSEcCtD
Sulindac—Dizziness—Clindamycin—malaria	0.000244	0.00106	CcSEcCtD
Sulindac—Vomiting—Dapsone—malaria	0.000243	0.00105	CcSEcCtD
Sulindac—Hypersensitivity—Quinidine barbiturate—malaria	0.000241	0.00105	CcSEcCtD
Sulindac—Hypersensitivity—Pentoxifylline—malaria	0.00024	0.00104	CcSEcCtD
Sulindac—Dizziness—Quinidine—malaria	0.000239	0.00104	CcSEcCtD
Sulindac—Dizziness—Quinine—malaria	0.000239	0.00104	CcSEcCtD
Sulindac—Headache—Dapsone—malaria	0.000239	0.00104	CcSEcCtD
Sulindac—Vomiting—Clindamycin—malaria	0.000235	0.00102	CcSEcCtD
Sulindac—Asthenia—Quinidine barbiturate—malaria	0.000234	0.00102	CcSEcCtD
Sulindac—Asthenia—Pentoxifylline—malaria	0.000234	0.00102	CcSEcCtD
Sulindac—Rash—Clindamycin—malaria	0.000233	0.00101	CcSEcCtD
Sulindac—Dermatitis—Clindamycin—malaria	0.000232	0.00101	CcSEcCtD
Sulindac—Headache—Clindamycin—malaria	0.000231	0.001	CcSEcCtD
Sulindac—Pruritus—Quinidine barbiturate—malaria	0.000231	0.001	CcSEcCtD
Sulindac—Pruritus—Pentoxifylline—malaria	0.000231	0.001	CcSEcCtD
Sulindac—Vomiting—Quinine—malaria	0.00023	0.000999	CcSEcCtD
Sulindac—Vomiting—Quinidine—malaria	0.00023	0.000999	CcSEcCtD
Sulindac—Rash—Quinidine—malaria	0.000228	0.000991	CcSEcCtD
Sulindac—Rash—Quinine—malaria	0.000228	0.000991	CcSEcCtD
Sulindac—Dermatitis—Quinidine—malaria	0.000228	0.00099	CcSEcCtD
Sulindac—Dermatitis—Quinine—malaria	0.000228	0.00099	CcSEcCtD
Sulindac—Headache—Quinine—malaria	0.000227	0.000985	CcSEcCtD
Sulindac—Headache—Quinidine—malaria	0.000227	0.000985	CcSEcCtD
Sulindac—Nausea—Dapsone—malaria	0.000227	0.000984	CcSEcCtD
Sulindac—Diarrhoea—Quinidine barbiturate—malaria	0.000224	0.000971	CcSEcCtD
Sulindac—Diarrhoea—Pentoxifylline—malaria	0.000223	0.000969	CcSEcCtD
Sulindac—Nausea—Clindamycin—malaria	0.000219	0.000952	CcSEcCtD
Sulindac—Dizziness—Quinidine barbiturate—malaria	0.000216	0.000938	CcSEcCtD
Sulindac—Dizziness—Pentoxifylline—malaria	0.000216	0.000936	CcSEcCtD
Sulindac—Nausea—Quinine—malaria	0.000215	0.000934	CcSEcCtD
Sulindac—Nausea—Quinidine—malaria	0.000215	0.000934	CcSEcCtD
Sulindac—Vomiting—Quinidine barbiturate—malaria	0.000208	0.000902	CcSEcCtD
Sulindac—Vomiting—Pentoxifylline—malaria	0.000207	0.0009	CcSEcCtD
Sulindac—Rash—Quinidine barbiturate—malaria	0.000206	0.000894	CcSEcCtD
Sulindac—Dermatitis—Quinidine barbiturate—malaria	0.000206	0.000894	CcSEcCtD
Sulindac—Rash—Pentoxifylline—malaria	0.000206	0.000893	CcSEcCtD
Sulindac—Dermatitis—Pentoxifylline—malaria	0.000205	0.000892	CcSEcCtD
Sulindac—Headache—Quinidine barbiturate—malaria	0.000205	0.000889	CcSEcCtD
Sulindac—Headache—Pentoxifylline—malaria	0.000204	0.000887	CcSEcCtD
Sulindac—Nausea—Quinidine barbiturate—malaria	0.000194	0.000843	CcSEcCtD
Sulindac—Nausea—Pentoxifylline—malaria	0.000194	0.000841	CcSEcCtD
Sulindac—ALB—Selenium Micronutrient Network—CRP—malaria	0.000118	0.00104	CbGpPWpGaD
Sulindac—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—CD36—malaria	0.000118	0.00104	CbGpPWpGaD
Sulindac—MAPK3—Cytokine Signaling in Immune system—IL18—malaria	0.000116	0.00103	CbGpPWpGaD
Sulindac—MAPK3—MicroRNAs in cardiomyocyte hypertrophy—TNF—malaria	0.000115	0.00102	CbGpPWpGaD
Sulindac—PTGS2—Metabolism of lipids and lipoproteins—DECR1—malaria	0.000115	0.00102	CbGpPWpGaD
Sulindac—MAPK3—Immune System—CISH—malaria	0.000115	0.00101	CbGpPWpGaD
Sulindac—PTGS1—Selenium Micronutrient Network—IL1B—malaria	0.000115	0.00101	CbGpPWpGaD
Sulindac—MAPK3—Cell Cycle, Mitotic—DHFR—malaria	0.000114	0.00101	CbGpPWpGaD
Sulindac—ALB—Vitamin B12 Metabolism—IL1B—malaria	0.000114	0.00101	CbGpPWpGaD
Sulindac—PTGS2—Aryl Hydrocarbon Receptor—TNF—malaria	0.000111	0.00098	CbGpPWpGaD
Sulindac—PTGS2—Spinal Cord Injury—TLR4—malaria	0.000111	0.000977	CbGpPWpGaD
Sulindac—MAPK3—NCAM signaling for neurite out-growth—IL6—malaria	0.00011	0.000973	CbGpPWpGaD
Sulindac—MAPK3—Cytokine Signaling in Immune system—HLA-B—malaria	0.00011	0.000971	CbGpPWpGaD
Sulindac—MAPK3—Immune System—FCGR2B—malaria	0.000109	0.000958	CbGpPWpGaD
Sulindac—ALB—Selenium Micronutrient Network—ICAM1—malaria	0.000109	0.000958	CbGpPWpGaD
Sulindac—MAPK3—TNF alpha Signaling Pathway—TNF—malaria	0.000107	0.000947	CbGpPWpGaD
Sulindac—MAPK3—Regulation of toll-like receptor signaling pathway—IL1B—malaria	0.000106	0.000938	CbGpPWpGaD
Sulindac—PTGS2—Spinal Cord Injury—ICAM1—malaria	0.000106	0.000937	CbGpPWpGaD
Sulindac—PTGS2—Spinal Cord Injury—NOS2—malaria	0.000105	0.000929	CbGpPWpGaD
Sulindac—MAPK3—Innate Immune System—FCGR2A—malaria	0.000105	0.000927	CbGpPWpGaD
Sulindac—ALB—Folate Metabolism—IFNG—malaria	0.000104	0.000918	CbGpPWpGaD
Sulindac—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—malaria	0.000104	0.000917	CbGpPWpGaD
Sulindac—MAPK3—Signaling by GPCR—ACKR1—malaria	0.000104	0.000917	CbGpPWpGaD
Sulindac—PTGS2—C-MYB transcription factor network—CD4—malaria	0.000102	0.000904	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism of lipids and lipoproteins—DECR1—malaria	0.000102	0.000903	CbGpPWpGaD
Sulindac—PTGS2—Selenium Micronutrient Network—IFNG—malaria	0.000102	0.000901	CbGpPWpGaD
Sulindac—MAPK3—Cell Cycle—DHFR—malaria	0.000102	0.000901	CbGpPWpGaD
Sulindac—MAPK3—TRAF6 Mediated Induction of proinflammatory cytokines—IL6—malaria	0.000102	0.0009	CbGpPWpGaD
Sulindac—MAPK3—Interferon Signaling—IFNG—malaria	0.000102	0.000899	CbGpPWpGaD
Sulindac—MAPK3—Toll-like Receptor Signaling Pathway—TNF—malaria	9.87e-05	0.000872	CbGpPWpGaD
Sulindac—CYP1A1—Aryl Hydrocarbon Receptor—TNF—malaria	9.85e-05	0.00087	CbGpPWpGaD
Sulindac—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TNF—malaria	9.85e-05	0.00087	CbGpPWpGaD
Sulindac—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—malaria	9.71e-05	0.000857	CbGpPWpGaD
Sulindac—MAPK3—Immune System—TIRAP—malaria	9.68e-05	0.000854	CbGpPWpGaD
Sulindac—MAPK3—Glucocorticoid receptor regulatory network—IL6—malaria	9.49e-05	0.000838	CbGpPWpGaD
Sulindac—ALB—Transmembrane transport of small molecules—SLC4A1—malaria	9.43e-05	0.000832	CbGpPWpGaD
Sulindac—ALB—Metabolism of lipids and lipoproteins—DECR1—malaria	9.32e-05	0.000823	CbGpPWpGaD
Sulindac—CYP1A2—Biological oxidations—HPGDS—malaria	9.3e-05	0.000821	CbGpPWpGaD
Sulindac—ALB—Folate Metabolism—IL1B—malaria	9.27e-05	0.000819	CbGpPWpGaD
Sulindac—ALB—Hemostasis—HBB—malaria	9.26e-05	0.000818	CbGpPWpGaD
Sulindac—PPARD—Metabolism—HPGDS—malaria	9.26e-05	0.000818	CbGpPWpGaD
Sulindac—ALB—Folate Metabolism—IL2—malaria	9.24e-05	0.000816	CbGpPWpGaD
Sulindac—MAPK3—MyD88 cascade initiated on plasma membrane—IL6—malaria	9.22e-05	0.000814	CbGpPWpGaD
Sulindac—MAPK3—IRS-mediated signalling—IL6—malaria	9.22e-05	0.000814	CbGpPWpGaD
Sulindac—MAPK3—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—IL6—malaria	9.13e-05	0.000806	CbGpPWpGaD
Sulindac—MAPK3—MAPK Signaling Pathway—IL1B—malaria	9.13e-05	0.000806	CbGpPWpGaD
Sulindac—PTGS2—Selenium Micronutrient Network—IL1B—malaria	9.11e-05	0.000804	CbGpPWpGaD
Sulindac—MAPK3—Immune System—CR1—malaria	8.99e-05	0.000794	CbGpPWpGaD
Sulindac—MAPK3—MyD88 dependent cascade initiated on endosome—IL6—malaria	8.97e-05	0.000792	CbGpPWpGaD
Sulindac—MAPK3—IRS-related events—IL6—malaria	8.97e-05	0.000792	CbGpPWpGaD
Sulindac—MAPK3—Cytokine Signaling in Immune system—ICAM1—malaria	8.94e-05	0.000789	CbGpPWpGaD
Sulindac—MAPK3—IRS-related events triggered by IGF1R—IL6—malaria	8.89e-05	0.000785	CbGpPWpGaD
Sulindac—MAPK3—TCR Signaling Pathway—IL6—malaria	8.81e-05	0.000778	CbGpPWpGaD
Sulindac—MAPK3—Spinal Cord Injury—TNF—malaria	8.79e-05	0.000776	CbGpPWpGaD
Sulindac—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—malaria	8.66e-05	0.000765	CbGpPWpGaD
Sulindac—MAPK3—Insulin receptor signalling cascade—IL6—malaria	8.65e-05	0.000764	CbGpPWpGaD
Sulindac—MAPK3—Toll Like Receptor 9 (TLR9) Cascade—IL6—malaria	8.65e-05	0.000764	CbGpPWpGaD
Sulindac—MAPK3—IGF1R signaling cascade—IL6—malaria	8.65e-05	0.000764	CbGpPWpGaD
Sulindac—MAPK3—TNF alpha Signaling Pathway—IL6—malaria	8.65e-05	0.000764	CbGpPWpGaD
Sulindac—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—malaria	8.63e-05	0.000762	CbGpPWpGaD
Sulindac—PPARD—Metabolism—DHFR—malaria	8.59e-05	0.000758	CbGpPWpGaD
Sulindac—MAPK3—MyD88:Mal cascade initiated on plasma membrane—IL6—malaria	8.51e-05	0.000751	CbGpPWpGaD
Sulindac—PPARD—Metabolism—SCARB1—malaria	8.5e-05	0.000751	CbGpPWpGaD
Sulindac—PTGS2—Integrated Pancreatic Cancer Pathway—FAS—malaria	8.37e-05	0.000739	CbGpPWpGaD
Sulindac—PTGS1—Selenium Micronutrient Network—TNF—malaria	8.32e-05	0.000735	CbGpPWpGaD
Sulindac—MAPK3—Disease—PKLR—malaria	8.3e-05	0.000733	CbGpPWpGaD
Sulindac—MAPK3—Axon guidance—KDR—malaria	8.29e-05	0.000732	CbGpPWpGaD
Sulindac—PTGDR2—GPCR downstream signaling—IL2—malaria	8.29e-05	0.000732	CbGpPWpGaD
Sulindac—ALB—Vitamin B12 Metabolism—TNF—malaria	8.27e-05	0.00073	CbGpPWpGaD
Sulindac—ALB—Selenium Micronutrient Network—IFNG—malaria	8.26e-05	0.000729	CbGpPWpGaD
Sulindac—MAPK3—MyD88-independent cascade—IL6—malaria	8.16e-05	0.000721	CbGpPWpGaD
Sulindac—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—CD36—malaria	8.11e-05	0.000716	CbGpPWpGaD
Sulindac—PTGS1—Metabolism—DHODH—malaria	8.09e-05	0.000714	CbGpPWpGaD
Sulindac—PTGS2—Spinal Cord Injury—IFNG—malaria	8.07e-05	0.000713	CbGpPWpGaD
Sulindac—MAPK3—Toll-like Receptor Signaling Pathway—IL6—malaria	7.97e-05	0.000704	CbGpPWpGaD
Sulindac—PTGS1—Metabolism of lipids and lipoproteins—HPGDS—malaria	7.95e-05	0.000702	CbGpPWpGaD
Sulindac—MAPK3—Senescence-Associated Secretory Phenotype (SASP)—IL6—malaria	7.79e-05	0.000687	CbGpPWpGaD
Sulindac—MAPK3—Regulation of toll-like receptor signaling pathway—TNF—malaria	7.71e-05	0.000681	CbGpPWpGaD
Sulindac—MAPK3—VEGFA-VEGFR2 Pathway—IL6—malaria	7.67e-05	0.000677	CbGpPWpGaD
Sulindac—MAPK3—Immune System—TLR9—malaria	7.65e-05	0.000675	CbGpPWpGaD
Sulindac—MAPK3—Signaling by Interleukins—IL6—malaria	7.61e-05	0.000672	CbGpPWpGaD
Sulindac—PTGDR2—Signaling by GPCR—IL2—malaria	7.53e-05	0.000665	CbGpPWpGaD
Sulindac—MAPK3—Disease—G6PD—malaria	7.4e-05	0.000654	CbGpPWpGaD
Sulindac—ALB—Selenium Micronutrient Network—IL1B—malaria	7.37e-05	0.000651	CbGpPWpGaD
Sulindac—MAPK3—Activated TLR4 signalling—IL6—malaria	7.34e-05	0.000648	CbGpPWpGaD
Sulindac—MAPK3—Platelet activation, signaling and aggregation—IL2—malaria	7.3e-05	0.000645	CbGpPWpGaD
Sulindac—PTGS1—Metabolism of lipids and lipoproteins—SCARB1—malaria	7.3e-05	0.000645	CbGpPWpGaD
Sulindac—MAPK3—Signaling by VEGF—IL6—malaria	7.24e-05	0.000639	CbGpPWpGaD
Sulindac—PTGS2—Spinal Cord Injury—IL1B—malaria	7.2e-05	0.000636	CbGpPWpGaD
Sulindac—MAPK3—Signaling by Insulin receptor—IL6—malaria	7.19e-05	0.000635	CbGpPWpGaD
Sulindac—PTGS2—Spinal Cord Injury—IL2—malaria	7.17e-05	0.000633	CbGpPWpGaD
Sulindac—MAPK3—Spinal Cord Injury—IL6—malaria	7.09e-05	0.000626	CbGpPWpGaD
Sulindac—MAPK3—Toll Like Receptor 4 (TLR4) Cascade—IL6—malaria	6.9e-05	0.00061	CbGpPWpGaD
Sulindac—PTGS1—Metabolism—SLC4A1—malaria	6.87e-05	0.000607	CbGpPWpGaD
Sulindac—PTGDR2—Signaling Pathways—KDR—malaria	6.86e-05	0.000606	CbGpPWpGaD
Sulindac—MAPK3—Developmental Biology—CD36—malaria	6.85e-05	0.000605	CbGpPWpGaD
Sulindac—MAPK3—Cytokine Signaling in Immune system—IFNG—malaria	6.8e-05	0.0006	CbGpPWpGaD
Sulindac—ALB—Folate Metabolism—TNF—malaria	6.73e-05	0.000594	CbGpPWpGaD
Sulindac—MAPK3—Hemostasis—CD36—malaria	6.72e-05	0.000593	CbGpPWpGaD
Sulindac—PTGS1—Selenium Micronutrient Network—IL6—malaria	6.72e-05	0.000593	CbGpPWpGaD
Sulindac—ALB—Vitamin B12 Metabolism—IL6—malaria	6.67e-05	0.000589	CbGpPWpGaD
Sulindac—MAPK3—MAPK Signaling Pathway—TNF—malaria	6.62e-05	0.000585	CbGpPWpGaD
Sulindac—PTGS2—Selenium Micronutrient Network—TNF—malaria	6.61e-05	0.000583	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism of lipids and lipoproteins—DECR1—malaria	6.52e-05	0.000576	CbGpPWpGaD
Sulindac—PTGS1—Metabolism—DECR1—malaria	6.46e-05	0.000571	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—DHODH—malaria	6.42e-05	0.000567	CbGpPWpGaD
Sulindac—PTGS2—Metabolism of lipids and lipoproteins—HPGDS—malaria	6.31e-05	0.000557	CbGpPWpGaD
Sulindac—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—malaria	6.28e-05	0.000555	CbGpPWpGaD
Sulindac—CYP1A2—Aryl Hydrocarbon Receptor—TNF—malaria	6.28e-05	0.000555	CbGpPWpGaD
Sulindac—ALB—Platelet activation, signaling and aggregation—CD36—malaria	6.27e-05	0.000554	CbGpPWpGaD
Sulindac—MAPK3—Regulation of toll-like receptor signaling pathway—IL6—malaria	6.22e-05	0.000549	CbGpPWpGaD
Sulindac—MAPK3—Innate Immune System—HLA-B—malaria	6.17e-05	0.000545	CbGpPWpGaD
Sulindac—MAPK3—Toll-Like Receptors Cascades—IL6—malaria	6.15e-05	0.000543	CbGpPWpGaD
Sulindac—MAPK3—Signaling by SCF-KIT—IL6—malaria	6.15e-05	0.000543	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—ACKR1—malaria	6.13e-05	0.000542	CbGpPWpGaD
Sulindac—MAPK3—Immune System—FCGR2A—malaria	6.11e-05	0.00054	CbGpPWpGaD
Sulindac—MAPK3—Cytokine Signaling in Immune system—IL1B—malaria	6.07e-05	0.000536	CbGpPWpGaD
Sulindac—MAPK3—Innate Immune System—CD36—malaria	6.05e-05	0.000534	CbGpPWpGaD
Sulindac—MAPK3—Cytokine Signaling in Immune system—IL2—malaria	6.04e-05	0.000534	CbGpPWpGaD
Sulindac—MAPK3—Integrated Pancreatic Cancer Pathway—TNF—malaria	5.98e-05	0.000528	CbGpPWpGaD
Sulindac—MAPK3—Developmental Biology—KDR—malaria	5.92e-05	0.000523	CbGpPWpGaD
Sulindac—MAPK3—Downstream signaling of activated FGFR—IL6—malaria	5.88e-05	0.00052	CbGpPWpGaD
Sulindac—PTGS1—Metabolism—HBB—malaria	5.85e-05	0.000516	CbGpPWpGaD
Sulindac—PTGS2—Metabolism of lipids and lipoproteins—SCARB1—malaria	5.8e-05	0.000512	CbGpPWpGaD
Sulindac—MAPK3—Signaling by ERBB4—IL6—malaria	5.79e-05	0.000511	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—DHODH—malaria	5.7e-05	0.000503	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism of lipids and lipoproteins—HPGDS—malaria	5.6e-05	0.000495	CbGpPWpGaD
Sulindac—MAPK3—Downstream signal transduction—IL6—malaria	5.53e-05	0.000488	CbGpPWpGaD
Sulindac—MAPK3—Hemostasis—NOS2—malaria	5.52e-05	0.000488	CbGpPWpGaD
Sulindac—MAPK3—Signaling by FGFR—IL6—malaria	5.5e-05	0.000486	CbGpPWpGaD
Sulindac—MAPK3—Signaling by ERBB2—IL6—malaria	5.48e-05	0.000484	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—SLC4A1—malaria	5.46e-05	0.000482	CbGpPWpGaD
Sulindac—MAPK3—Innate Immune System—CRP—malaria	5.45e-05	0.000481	CbGpPWpGaD
Sulindac—MAPK3—DAP12 signaling—IL6—malaria	5.45e-05	0.000481	CbGpPWpGaD
Sulindac—ALB—Folate Metabolism—IL6—malaria	5.43e-05	0.000479	CbGpPWpGaD
Sulindac—ALB—Selenium Micronutrient Network—TNF—malaria	5.35e-05	0.000472	CbGpPWpGaD
Sulindac—PPARD—Metabolism—CD36—malaria	5.34e-05	0.000471	CbGpPWpGaD
Sulindac—PTGS2—Selenium Micronutrient Network—IL6—malaria	5.33e-05	0.000471	CbGpPWpGaD
Sulindac—MAPK3—Disease—DHFR—malaria	5.24e-05	0.000462	CbGpPWpGaD
Sulindac—MAPK3—Innate Immune System—TLR4—malaria	5.23e-05	0.000462	CbGpPWpGaD
Sulindac—PTGS2—Spinal Cord Injury—TNF—malaria	5.23e-05	0.000461	CbGpPWpGaD
Sulindac—PTGS1—Metabolism—PKLR—malaria	5.21e-05	0.00046	CbGpPWpGaD
Sulindac—ALB—Metabolism—DHODH—malaria	5.19e-05	0.000459	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism of lipids and lipoproteins—SCARB1—malaria	5.14e-05	0.000454	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—DECR1—malaria	5.13e-05	0.000453	CbGpPWpGaD
Sulindac—MAPK3—Fc epsilon receptor (FCERI) signaling—IL6—malaria	5.13e-05	0.000453	CbGpPWpGaD
Sulindac—MAPK3—DAP12 interactions—IL6—malaria	5.13e-05	0.000453	CbGpPWpGaD
Sulindac—MAPK3—Signaling by FGFR in disease—IL6—malaria	5.13e-05	0.000453	CbGpPWpGaD
Sulindac—ALB—Metabolism of lipids and lipoproteins—HPGDS—malaria	5.11e-05	0.000451	CbGpPWpGaD
Sulindac—MAPK3—Signaling by EGFR—IL6—malaria	5.08e-05	0.000449	CbGpPWpGaD
Sulindac—MAPK3—Signaling by EGFR in Cancer—IL6—malaria	5.04e-05	0.000445	CbGpPWpGaD
Sulindac—MAPK3—Signaling by PDGF—IL6—malaria	5.01e-05	0.000443	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—TLR9—malaria	4.94e-05	0.000437	CbGpPWpGaD
Sulindac—PTGS2—Disease—PKLR—malaria	4.94e-05	0.000436	CbGpPWpGaD
Sulindac—MAPK3—Cellular Senescence—IL6—malaria	4.93e-05	0.000435	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—SLC4A1—malaria	4.84e-05	0.000428	CbGpPWpGaD
Sulindac—ALB—Metabolism of lipids and lipoproteins—SCARB1—malaria	4.69e-05	0.000414	CbGpPWpGaD
Sulindac—PTGS1—Metabolism—G6PD—malaria	4.64e-05	0.00041	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—HBB—malaria	4.64e-05	0.00041	CbGpPWpGaD
Sulindac—PTGS1—Metabolism of lipids and lipoproteins—CD36—malaria	4.58e-05	0.000405	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—DECR1—malaria	4.55e-05	0.000402	CbGpPWpGaD
Sulindac—MAPK3—NGF signalling via TRKA from the plasma membrane—IL6—malaria	4.54e-05	0.000401	CbGpPWpGaD
Sulindac—PTGDR2—Signaling Pathways—IL2—malaria	4.45e-05	0.000393	CbGpPWpGaD
Sulindac—PTGDR2—Signaling by GPCR—IL6—malaria	4.42e-05	0.000391	CbGpPWpGaD
Sulindac—ALB—Metabolism—SLC4A1—malaria	4.42e-05	0.00039	CbGpPWpGaD
Sulindac—PTGS2—Disease—G6PD—malaria	4.4e-05	0.000389	CbGpPWpGaD
Sulindac—MAPK3—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—malaria	4.39e-05	0.000387	CbGpPWpGaD
Sulindac—ALB—Selenium Micronutrient Network—IL6—malaria	4.31e-05	0.000381	CbGpPWpGaD
Sulindac—PTGS2—Spinal Cord Injury—IL6—malaria	4.22e-05	0.000372	CbGpPWpGaD
Sulindac—ALB—Metabolism—DECR1—malaria	4.15e-05	0.000367	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—PKLR—malaria	4.14e-05	0.000365	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—HBB—malaria	4.12e-05	0.000364	CbGpPWpGaD
Sulindac—MAPK3—Immune System—IL18—malaria	3.79e-05	0.000335	CbGpPWpGaD
Sulindac—MAPK3—Immune System—CD40LG—malaria	3.78e-05	0.000334	CbGpPWpGaD
Sulindac—MAPK3—Hemostasis—IL2—malaria	3.76e-05	0.000332	CbGpPWpGaD
Sulindac—ALB—Metabolism—HBB—malaria	3.75e-05	0.000331	CbGpPWpGaD
Sulindac—MAPK3—Immune System—CD8A—malaria	3.74e-05	0.00033	CbGpPWpGaD
Sulindac—MAPK3—Cellular responses to stress—IL6—malaria	3.72e-05	0.000329	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—G6PD—malaria	3.69e-05	0.000326	CbGpPWpGaD
Sulindac—MAPK3—Innate Immune System—CD4—malaria	3.68e-05	0.000325	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—PKLR—malaria	3.67e-05	0.000324	CbGpPWpGaD
Sulindac—PTGS2—Metabolism of lipids and lipoproteins—CD36—malaria	3.64e-05	0.000321	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—DHODH—malaria	3.63e-05	0.000321	CbGpPWpGaD
Sulindac—MAPK3—Immune System—HLA-B—malaria	3.59e-05	0.000317	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism of lipids and lipoproteins—HPGDS—malaria	3.57e-05	0.000315	CbGpPWpGaD
Sulindac—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—malaria	3.55e-05	0.000314	CbGpPWpGaD
Sulindac—MAPK3—Cytokine Signaling in Immune system—IL6—malaria	3.55e-05	0.000314	CbGpPWpGaD
Sulindac—PTGS1—Metabolism—HPGDS—malaria	3.54e-05	0.000313	CbGpPWpGaD
Sulindac—MAPK3—Immune System—CD36—malaria	3.52e-05	0.000311	CbGpPWpGaD
Sulindac—ALB—Platelet activation, signaling and aggregation—IL2—malaria	3.51e-05	0.00031	CbGpPWpGaD
Sulindac—MAPK3—Signaling by NGF—IL6—malaria	3.49e-05	0.000308	CbGpPWpGaD
Sulindac—ALB—Metabolism—PKLR—malaria	3.35e-05	0.000295	CbGpPWpGaD
Sulindac—PTGS1—Metabolism—DHFR—malaria	3.29e-05	0.00029	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism of lipids and lipoproteins—SCARB1—malaria	3.28e-05	0.00029	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—G6PD—malaria	3.27e-05	0.000289	CbGpPWpGaD
Sulindac—PTGS1—Metabolism—SCARB1—malaria	3.25e-05	0.000287	CbGpPWpGaD
Sulindac—ALB—Hemostasis—CD36—malaria	3.23e-05	0.000285	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism of lipids and lipoproteins—CD36—malaria	3.23e-05	0.000285	CbGpPWpGaD
Sulindac—MAPK3—Immune System—CRP—malaria	3.18e-05	0.00028	CbGpPWpGaD
Sulindac—MAPK3—Axon guidance—IL6—malaria	3.16e-05	0.000279	CbGpPWpGaD
Sulindac—PTGS2—Disease—DHFR—malaria	3.11e-05	0.000275	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—SLC4A1—malaria	3.09e-05	0.000273	CbGpPWpGaD
Sulindac—MAPK3—Immune System—TLR4—malaria	3.04e-05	0.000269	CbGpPWpGaD
Sulindac—ALB—Metabolism—G6PD—malaria	2.98e-05	0.000263	CbGpPWpGaD
Sulindac—ALB—Metabolism of lipids and lipoproteins—CD36—malaria	2.94e-05	0.00026	CbGpPWpGaD
Sulindac—MAPK3—Immune System—ICAM1—malaria	2.92e-05	0.000258	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—DECR1—malaria	2.9e-05	0.000256	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—HPGDS—malaria	2.81e-05	0.000248	CbGpPWpGaD
Sulindac—MAPK3—Developmental Biology—TNF—malaria	2.79e-05	0.000247	CbGpPWpGaD
Sulindac—MAPK3—Disease—NOS2—malaria	2.67e-05	0.000236	CbGpPWpGaD
Sulindac—ALB—Hemostasis—NOS2—malaria	2.66e-05	0.000235	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—HBB—malaria	2.63e-05	0.000232	CbGpPWpGaD
Sulindac—PTGDR2—Signaling Pathways—IL6—malaria	2.61e-05	0.000231	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—DHFR—malaria	2.61e-05	0.00023	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—SCARB1—malaria	2.58e-05	0.000228	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—HPGDS—malaria	2.5e-05	0.00022	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—PKLR—malaria	2.34e-05	0.000207	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—DHFR—malaria	2.31e-05	0.000204	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—SCARB1—malaria	2.29e-05	0.000202	CbGpPWpGaD
Sulindac—ALB—Metabolism—HPGDS—malaria	2.27e-05	0.000201	CbGpPWpGaD
Sulindac—MAPK3—Developmental Biology—IL6—malaria	2.26e-05	0.000199	CbGpPWpGaD
Sulindac—MAPK3—Immune System—IFNG—malaria	2.22e-05	0.000196	CbGpPWpGaD
Sulindac—MAPK3—Signaling by GPCR—IL2—malaria	2.16e-05	0.000191	CbGpPWpGaD
Sulindac—MAPK3—Immune System—CD4—malaria	2.15e-05	0.000189	CbGpPWpGaD
Sulindac—ALB—Metabolism—DHFR—malaria	2.11e-05	0.000186	CbGpPWpGaD
Sulindac—ALB—Metabolism—SCARB1—malaria	2.09e-05	0.000184	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—G6PD—malaria	2.09e-05	0.000184	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism of lipids and lipoproteins—CD36—malaria	2.06e-05	0.000182	CbGpPWpGaD
Sulindac—PTGS1—Metabolism—CD36—malaria	2.04e-05	0.00018	CbGpPWpGaD
Sulindac—MAPK3—Innate Immune System—IL6—malaria	1.99e-05	0.000176	CbGpPWpGaD
Sulindac—MAPK3—Immune System—IL1B—malaria	1.98e-05	0.000175	CbGpPWpGaD
Sulindac—MAPK3—Disease—CD4—malaria	1.98e-05	0.000175	CbGpPWpGaD
Sulindac—MAPK3—Immune System—IL2—malaria	1.97e-05	0.000174	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—KDR—malaria	1.97e-05	0.000174	CbGpPWpGaD
Sulindac—ALB—Hemostasis—IL2—malaria	1.81e-05	0.00016	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—CD36—malaria	1.62e-05	0.000143	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—HPGDS—malaria	1.59e-05	0.00014	CbGpPWpGaD
Sulindac—PTGS2—Disease—NOS2—malaria	1.59e-05	0.00014	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—DHFR—malaria	1.48e-05	0.00013	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—SCARB1—malaria	1.46e-05	0.000129	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—CD36—malaria	1.44e-05	0.000127	CbGpPWpGaD
Sulindac—ALB—Metabolism—CD36—malaria	1.31e-05	0.000116	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—IL2—malaria	1.28e-05	0.000113	CbGpPWpGaD
Sulindac—MAPK3—Signaling by GPCR—IL6—malaria	1.27e-05	0.000112	CbGpPWpGaD
Sulindac—PTGS2—Disease—CD4—malaria	1.18e-05	0.000104	CbGpPWpGaD
Sulindac—MAPK3—Immune System—IL6—malaria	1.16e-05	0.000102	CbGpPWpGaD
Sulindac—MAPK3—Disease—IL6—malaria	1.07e-05	9.46e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—CD36—malaria	9.17e-06	8.09e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—IL6—malaria	7.5e-06	6.62e-05	CbGpPWpGaD
Sulindac—PTGS2—Disease—IL6—malaria	6.37e-06	5.62e-05	CbGpPWpGaD
